OBJECTIVE： To explore the characteristics and regularity of ADR induced by gynecological Chinese patent medicine， and to provide reference for rational use of gynecological Chinese patent medicine. METHODS： ADR reports were collected from gynecological ADR reporting information system of our hospital during 2008-2105； all ADR cases of Chinese patent medicine were collected and analyzed. RESULTS： No severe ADR was found among 41 cases of Chinese patent medicine-induced ADR， 24 cases of new and common ADR （58.54％）， 17 cases of common ADR （41.46％）； the incidence of ADR was in high level 1-3 d after medicating， being 97.6％. Main routes of administration were oral administration （19 cases， 46.3％） and vaginal administration （15 cases， 36.6％） in ADR cases. Clinical manifestations were gastrointestinal reaction （29.97％）， systemic reaction （19.15％） and mild injury of reproductive system （17.02％）， etc. CONCLUSIONS： Chinese patent medicine is relatively safety in gynecological department. However， caution should be exercised in special cases and different medication.